Dr. Reddys Laboratories Ltd.

Dr Reddy's Laboratories has earmarked a capex of around Rs 1,500 crore for FY23 with major part of it slated to go into building capacities for its biosimilar and injectable businesses. The company also plans to utilise the capital for adding capacities to existing plants, firm up R&D activities and further invest in digitisation projects.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.